Caplin Point Laboratories Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: CAPLIPOINT BSE: 524742

₹2716.40

Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #28 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	435,863	146.5	13.7%	11.0%	—	72	8	30
Divi's Laboratories Limited	246,660	83.9	15.3%	62.7%	0.32%	70	4	51
Torrent Pharmaceuticals Limited	162,454	78.2	12.2%	34.6%	0.79%	56	0	31
Zydus Lifesciences Limited	115,910	33.3	17.3%	17.2%	0.09%	74	24	84
Cipla Limited	108,736	35.4	11.2%	-11.0%	0.97%	73	29	62
Laurus Labs Limited	106,969	122.5	17.1%	127.1%	—	78	24	53
Mankind Pharma Limited	103,406	47.4	11.7%	2.6%	—	68	12	86
Dr. Reddy's Laboratories Limited	102,916	154.7	10.9%	-0.9%	—	62	33	71
Caplin Point Laboratories Limited (this stock)	20,648	47.9	17.9%	32.0%	—	72	20	50

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹20,604 Cr

EV / EBITDA

36.8x

EV / Sales

27.16x

Market cap / Sales

27.21x

Earnings yield

2.09%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 266 Cr, up 23.8% YoY.

↑ Positive

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 120 Cr, up 40.2% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	203	151	120	₹15.8400
March 31, 2026	191	138	110	₹15.8900
Dec. 31, 2025	189	117	87	₹11.4900
Sept. 30, 2025	175	129	103	₹13.5000
June 30, 2025	183	112	86	₹11.3000
March 31, 2025	174	110	86	₹11.3700
Dec. 31, 2024	185	100	75	₹9.8300
Sept. 30, 2024	208	135	106	₹13.9200
June 30, 2024	186	97	73	₹9.5500
March 31, 2024	139	87	70	₹9.2000
Dec. 31, 2023	133	74	55	₹7.3010
Sept. 30, 2023	179	107	82	₹10.8160
June 30, 2023	174	97	76	₹10.0400

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	266	252	221	234	215	215	214	251	207	176	151	204	201
Operating revenue	203	191	189	175	183	174	185	208	186	139	133	179	174
Other income	63	61	32	59	32	41	29	43	22	36	18	24	27
Operating expenses	109	108	98	99	96	99	108	110	104	82	70	90	97
Operating profit	94	84	92	76	87	75	77	98	81	58	63	89	77
Operating profit margin	46.5%	43.7%	48.5%	43.3%	47.4%	43.2%	41.8%	47.2%	43.8%	41.4%	47.7%	49.9%	44.1%
Depreciation	7	7	6	6	6	6	6	6	6	7	7	7	7
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0
Exceptional items, gain / (loss)	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit before tax	151	138	117	129	112	110	100	135	97	87	74	107	97
Tax	30	28	30	26	27	24	25	29	24	17	19	25	21
Net profit	120	110	87	103	86	86	75	106	73	70	55	82	76
EPS	15.84	15.89	11.49	13.50	11.30	11.37	9.83	13.92	9.55	9.20	7.30	10.82	10.04
Net profit (TTM)	420	385	362	350	353	339	323	304	280	284	268	272	247
EPS (TTM)	56.72	52.18	47.66	46.00	46.42	44.67	42.50	39.97	36.87	37.36	35.31	35.81	32.58

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	738	508	397
March 31, 2025	752	442	339
March 31, 2024	625	366	284
March 31, 2023	529	293	234

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	13.7%	13.0%	922^†	887^†	731^†	628^†	585^†	501^†	572^†	450^†	354^†
Operating revenue	11.8%	8.9%	738	752	625	529	528^†	483^†	537^†	438^†	348^†
Other income	—	—	184^†	135^†	106^†	99^†	57^†	19^†	35^†	12^†	6^†
Operating expenses	—	—	401^†	420^†	338^†	309^†	308^†	269^†	349^†	285^†	—
Operating profit	15.4%	9.6%	338^†	332^†	287^†	220^†	220^†	214^†	188^†	153^†	—
Operating profit margin	—	—	45.7%^†	44.1%^†	45.9%^†	41.6%^†	41.6%^†	44.3%^†	35.0%^†	35.0%^†	—
Depreciation	—	—	25^†	25^†	27^†	26^†	26^†	22^†	21^†	19^†	13^†
Interest	—	—	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†	—
Exceptional items, gain / (loss)	—	—	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†
Profit before tax	20.1%	19.3%	508	442	366	293	250^†	210^†	203^†	146^†	93^†
Tax	—	—	111^†	102^†	82^†	59^†	62^†	54^†	54^†	44^†	23^†
Net profit	19.2%	20.5%	397	339	284	234	188^†	156^†	148^†	102^†	71^†
EPS	19.1%	20.4%	52.18^†	44.67^†	37.36^†	30.88^†	24.82^†	20.64^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 19	Mar 18	Mar 17
Operating margin	45.7%^†	44.1%^†	45.9%^†	41.6%^†	41.6%^†	44.3%^†	35.0%^†	35.0%^†	—
EBIT margin	68.8%^†	58.7%^†	58.5%^†	55.5%^†	47.4%^†	43.5%^†	37.8%^†	33.4%^†	—
PBT margin	68.7%	58.7%	58.5%	55.5%	47.4%^†	43.5%^†	37.7%^†	33.3%^†	26.9%^†
Net margin	53.7%	45.1%	45.4%	44.3%	35.6%^†	32.4%^†	27.6%^†	23.4%^†	20.4%^†
Interest coverage	2417.76x^†	3681.58x^†	3622.19x^†	2443.92x^†	2782.00x^†	1313.25x^†	3389.88x^†	2387.50x^†	—
Dividend payout	—	—	—	—	—	—	—	—	—
Earnings retention	—	—	—	—	—	—	—	—	—
Current ratio	6.77x	8.27x	—	—	—	—	—	—	—
Quick ratio	6.17x	7.61x	—	—	—	—	—	—	—
Debt to equity	0.00x	0.00x	—	—	—	—	—	—	—
Return on equity	19.3%	20.0%	—	—	—	—	—	—	—
Return on assets	17.9%	18.7%	—	—	—	—	—	—	—
Return on capital employed	24.6%^†	25.8%^†	—	—	—	—	—	—	—
Asset turnover	0.33x	0.41x	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	215	-225	-46	45	170
March 31, 2025	196	-140	-38	57	139
March 31, 2024	104	-112	-34	23	81
March 31, 2023	157	-87	-30	59	98
March 31, 2022	231	-237	-23	7	224

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	2,212	2,050	2,035	0	0	976	144	44	220	86
March 31, 2025	1,814	1,701	1,686	0	0	826	100	100	202	66
March 31, 2024	—	—	—	—	—	—	—	—	—	—
March 31, 2023	—	—	—	—	—	—	—	—	—	—
March 31, 2022	—	—	—	—	—	—	—	—	—	—

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.